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The plant VTC2 gene encodes GDP-L-galactose phosphorylase,
a rate-limiting enzyme in plant vitamin C biosynthesis. Genes
encoding apparent orthologs of VTC2 exist in both mammals,
which produce vitamin C by a distinct metabolic pathway, and in
the nematode wormCaenorhabditis eleganswhere vitamin C bio-
synthesis has not been demonstrated. We have now expressed
cDNAs of the human and worm VTC2 homolog genes (C15orf58
andC10F3.4, respectively)andfoundthat thepurifiedproteinsalso
display GDP-hexose phosphorylase activity. However, as opposed
to theplant enzyme, themajor reactioncatalyzedby theseenzymes
is the phosphorolysis of GDP-D-glucose to GDP and D-glucose
1-phosphate.Wedetectedactivitieswithsimilar substrate specific-
ity in worm and mouse tissue extracts. The highest expression of
GDP-D-glucose phosphorylase was found in the nervous andmale
reproductive systems. A C. elegans C10F3.4 deletion strain was
found to totally lack GDP-D-glucose phosphorylase activity; this
activity was also found to be decreased in human HEK293T cells
transfected with siRNAs against the humanC15orf58 gene. These
observations confirm the identification of the worm C10F3.4 and
the human C15orf58 gene expression products as the GDP-D-glu-
cose phosphorylases of these organisms. Significantly,we foundan
accumulation of GDP-D-glucose in the C10F3.4 mutant worms,
suggesting that theGDP-D-glucose phosphorylasemay function to
remove GDP-D-glucose formed by GDP-D-mannose pyrophos-
phorylase, an enzyme that has previously been shown to lack spec-
ificity for its physiological D-mannose 1-phosphate substrate. We
propose that such removal may prevent the misincorporation of
glucosyl residues formannosyl residues into theglycoconjugatesof
worms andmammals.
The last missing enzyme of the plant vitamin C biosynthesis
pathway was recently identified as a GDP-L-galactose phosphor-
ylase encoded by the Arabidopsis VTC2 gene (1, 2). In this
10-step metabolic pathway from D-glucose to L-ascorbate,
GDP-L-Gal4 phosphorylase catalyzes the formation of L-Gal-
1-P in the first committed (andhighly regulated) step to vitamin
C biosynthesis (2–5). Intriguingly, theVTC2 gene appears to be
conserved in vertebrates, which are known to synthesize vita-
min C via a different metabolic pathway than plants that does
not include GDP-L-Gal as an intermediate (6), and in inverte-
brates such as Caenorhabditis elegans that may lack the ability
to synthesize vitaminC (1). The physiological functions of these
apparent orthologs are thus unclear. One clue may be that the
Arabidopsis VTC2 enzyme can also use GDP-D-glucose as a
substrate (1). Although the role of this activity in plants is
unclear, such an activity may be important in other species.
Whereas GDP-L-Gal is most probably absent frommammalian
tissues, the presence of GDP-D-Glc in bovine mammary gland
and the existence of a mammalian GDP-D-Glc pyrophosphory-
lase have been reported (7, 8).More recent observations suggest
that GDP-D-Glc formation can be catalyzed by the mammalian
GDP-D-mannose pyrophosphorylase (9, 10). Nometabolic role
of GDP-D-Glc in mammalian tissues has been proposed, how-
ever, and nothing is known about this metabolite in C. elegans.
The Arabidopsis VTC2 protein and its invertebrate and ver-
tebrate homologs are members of the histidine triad (HIT)
superfamily of proteins, which includes nucleotide hydrolases
and transferases (11). Known substrates of this superfamily
of enzymes include AMP-lysine, diadenosine polyphosphate,
AMP-sulfate, and nucleotide sugars such as UDP-D-Glc and
ADP-D-Glc in addition to GDP-L-Gal (12). HIT enzymes are
characterized by the presence of a HXHX(H/Q) motif (X rep-
resents a hydrophobic amino acid), the second histidine residue
of which generally attacks the -phosphate of the nucleotide
substrate. This leads to release of the leaving group and nucle-
otidylation of the enzyme. The nucleotidylated enzyme is then
resolved by either hydrolysis or, in the case of transferases and
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phosphorylases, transfer to a second phosphorylated substrate
or inorganic phosphate, respectively (4, 12).
In the present work, we overexpressed and purified the C.
elegans and human VTC2 homolog gene products (C10F3.4
and C15orf58, respectively) and determined their kinetic prop-
erties as well as their substrate specificities.We found that both
genes encode GDP-D-Glc phosphorylases with properties very
similar to each other and to GDP-D-Glc phosphorylase activity
detected inC. elegans andmouse tissue extracts.We confirmed
the molecular identity of this enzyme by using aC10F3.4worm
deletion strain and by performing siRNA experiments in
HEK293T cells. Based on the accumulation of GDP-D-Glc inC.
elegans worms lacking the VTC2 homolog, we propose a phys-
iological role for GDP-D-Glc phosphorylase in removing the
GDP-D-Glc formed by the nonspecific enzyme GDP-D-man-
nose pyrophosphorylase to limit its misincorporation into gly-
coproteins and other glycoconjugates.
EXPERIMENTAL PROCEDURES
Materials—ADP-D-Glc, GDP-D-Glc, GDP-D-Man, UDP-D-
Gal, UDP-D-Glc, D-Gal-1-P, D-Glc-1-P, D-Man-1-P (all of these
nucleotide sugars and hexose phosphates were in the -
configuration), GDP--L-Fuc, GDP, glucose-6-P dehydrogen-
ase from Leuconostoc mesenteroides, and -nicotinamide ade-
nine dinucleotide (NAD) were from Sigma. L-Gal-1-P was from
Glycoteam (Hamburg, Germany). Phosphoglucomutase (-D-
glucose-1,6-bisphosphate:-D-glucose-1-phosphate phospho-
transferase) from rabbit muscle was purchased from OYC
Americas (Andover, MA). All other reagents were of analytical
grade. GDP--L-Gal, synthesized and purified as described
(13), was provided by Prof. Shinichi Kitamura (Osaka Prefec-
ture University). This preparation was further purified by the
reverse-phase HPLC method described previously (1). Frac-
tions containing GDP-L-Gal were lyophilized, resuspended in
H2O, and stored at20 °C.
C. elegans Strains and Culture Conditions—Standard proce-
dures used to maintain C. elegans strains were adapted from
Sulston and Hodgkin (14). M9 and S media were prepared as
described by Lewis and Fleming (15). The N2 strain was
obtained from the Caenorhabditis Genetics Center (St. Paul,
MN). The C10F3.4 mutant strain (tm2679) lacking coding
sequences between exons 5 and 8 of the C10F3.4 gene (Worm-
Base), was provided by the C. elegans Core Facility at Tokyo
Women’s Medical University. We also used a transgenic strain
expressing a C10F3.4::GFP fusion protein under the endoge-
nous C10F3.4 promoter (see “Transgenic Worm Construction
andAnalysis”).C. elegans strains were cultured at 20 °C accord-
ing to standard procedures (16). All strains were maintained at
20 °C on nematode growth medium plates streaked with Esch-
erichia coli OP50 (14). Liquid cultures of these worm strains
were grown at 20 °C in S medium supplemented with concen-
trated E. coli OP50, and worms were harvested, washed, and
sucrose-floated as described previously (17) except that M9
medium was used instead of 0.1 M NaCl as a resuspension and
washing solution.
Transgenic Worm Construction and Analysis—The C10F3.4::
GFP fusion construct and the transgenic lines expressing the
C10F3.4::GFP fusion protein were generated at the Worm Core
Facility (University ofUtah). TheC10F3.4::GFP construct, placing
theC10F3.4 gene as well as the 3-kb genomic region immediately
upstream of the C10F3.4 transcription start site in-frame with
GFP, was made via a PCR fusion procedure described previously
(18). The primer sequences used for this fusion procedurewere as
follows: 5-TGATCAGTTGGGACCCACCATGAG-3, 5-CTT-
TGGCCAATCCCGGGGATCTTTCGATCCCTCGTCAGAT-
TGAGC-3, 5-GCTCAATCTGACGAGGGATCGAAAGATC-
CCCGGGATTGGCCAAAG-3, and 5-AGCACGAACAACT-
CGGGGTGA-3. The C10F3.4::GFP fusion construct was
injectedat 5ng/l alongwith80ng/l pRF4andpBlueScriptKSat
35 ng/l into the gonad arms of N2 adult hermaphrodites. Trans-
genic animals of the N2 xtEX85(C10F3.4::GFP, pRF4) genotype
were identified by the Rol phenotype, and stable lines were iso-
lated. The isolated line used in this study was designatedUZ119.
Cloning and Expression of C. elegans C10F3.4—The C.
elegans C10F3.4a coding sequence was PCR-amplified from an
Invitrogen ProQuest C. elegans cDNA library in the vector
pPC86 (catalog number 11288-016) using forward primer
5-CACCATGGAGCCTTTTCCGCGAATC-3 and reverse
primer 5-TCATTTCGATCCCTCGTCAGATTG-3. The
ProQuest cDNA library was prepared from RNA extracted
fromamixed population of adult and larval nematodeworms of
the N2 strain. The PCR product was purified and cloned into
the Champion pET100/D-Topo vector (Invitrogen), and the
recombinant plasmid was transformed into E. coli BL21 Star
(DE3) cells. The transformed E. coli cells were grown at 37 °C in
LBmedium containing 50g/ml carbenicillin (Sigma) until the
optical density at 600 nm reached a value of about 0.6. Recom-
binant protein production was induced by the addition of 0.4
mM isopropyl-D-thiogalactopyranoside.After overnight incu-
bation with shaking at 18 °C, cells were harvested, washed, and
frozen at80 °C. Cells were then thawed; resuspended in a pH
8.0 buffer containing 50 mM sodium phosphate, 500 mM NaCl,
5 mM -mercaptoethanol, 5% glycerol, Roche Applied Science
Complete protease inhibitor mixture (1 tablet/50 ml), and 10
units/ml Benzonase nuclease (Novagen); and lysed by sonica-
tion as described (19). The lysate was centrifuged for 60 min at
13,000 g at 4 °C. The resulting supernatant was loaded onto a
5-ml HisTrap HP nickel affinity column (GE Healthcare), and
His-tagged C10F3.4 protein was eluted using a gradient of
20–500 mM imidazole according to the manufacturer’s specifi-
cations. Peak protein fractions containing the C10F3.4 protein
were pooled, and buffer was exchanged to 10 mM HEPES, pH
7.5, 100 mM NaCl, and 1 mM dithiothreitol in a 10-kDa-cutoff
Amicon Ultra centrifugal filter unit (Millipore, Billerica, MA).
Protein concentration was determined using a Lowry assay
after precipitation with 10% trichloroacetic acid. SDS-PAGE
analysis of the purified enzyme preparation used throughout
this study revealed a single band at the expected molecular
weight for the His-tagged C10F3.4 protein after Coomassie
Blue staining. The purified enzymewas stored at80 °C in 10%
glycerol.
Cloning and Expression of Human C15orf58—The Human
ORFeome Collaboration Clone 100016258, a Gateway Entry
vector containing the predicted complete cDNA coding
sequence of the human C15orf58 gene (GenBankTM accession
number BC153017), was purchased from Open Biosystems
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(Huntsville, AL). This Entry clone was used in LR recombina-
tion reactions (Invitrogen) with the T7 promoter expression
vector pDEST17 to obtain a construct for production of recom-
binant C15orf58 protein with an N-terminally fused hexahisti-
dine tag as described by the manufacturer. This construct was
transformed into E. coli BL21 Star (DE3) cells for protein over-
expression. Recombinant human C15orf58 protein was pro-
duced and purified as described for recombinant C. elegans
C10F3.4 protein with the exception that a 5–500mM imidazole
gradient was used for elution of His-tagged C15orf58. Protein
concentration was determined using a Lowry assay after pre-
cipitation with 10% trichloroacetic acid. Protein purity was
determined by SDS-PAGEanalysis usingCoomassie Blue stain-
ing followed by densitometry using the NIH ImageJ software;
recombinant C15orf58 protein was estimated to represent 17%
of the total protein present in the enzyme preparation used
throughout this study. The contaminating proteins present in
this preparation did not interfere with our enzymatic assays
(absence of significant hydrolytic activities acting on GDP-sug-
ars orGDP), and recombinantC15orf58was therefore not puri-
fied further. The purified enzyme preparation was stored at
80 °C in 10% glycerol.
siRNA Transfection and Extraction of HEK293T Cells—
HEK293T cells weremaintained inDulbecco’smodified Eagle’s
medium (DMEM) supplemented with 10% heat-inactivated
fetal calf serum, 1% penicillin/streptomycin, and 2 mM Ultra-
Glutamine in an atmosphere of 5% CO2 in air. For transfection
of cells with siRNAs, HEK293T cells were plated at a density of
about 800,000 cells/9.6-cm2well. Cells were transfected the fol-
lowing day using 50 nM control siRNA (Dharmacon ON-
TARGETplus non-targeting pool from Thermo Scientific
(Epsom, UK)) or 50 nM C15orf58 siRNA (Dharmacon
ON-TARGETplus SMARTpool from Thermo Scientific) and 6
l of the transfection reagent Lipofectamine 2000 (Invitrogen)
in the absence of antibiotics in the culture medium according
to the manufacturer’s instructions. The culture medium was
replaced by freshmedium containing antibiotics about 6 h after
addition of the RNA-Lipofectamine 2000 complexes. After
48–72 h, the cells were either washed with cold phosphate-
buffered saline (PBS) and resuspended in lysis buffer containing
25mMHEPES, pH 7.1, 5g/ml antipain, and 5g/ml leupeptin
for protein extraction or resuspended in TriPure Isolation Rea-
gent (Roche Applied Science) for total RNA extraction. For
protein extraction, cells were lysed by one cycle of freeze-thaw-
ing and centrifuged. The resulting supernatant was used to
assay GDP-D-Glc phosphorylase activity by the HPLC method
described below. Protein concentration in these extracts was
determined by the Lowry assay after protein precipitation with
10% trichloroacetic acid. Total RNA was isolated from the Tri-
Pure cell extracts after phase separation using chloroform
according to the manufacturer’s instructions. The RNA con-
centration was determined bymeasuring the absorbance at 260
nm, and the samples were stored at80 °C.
Quantitative Real Time PCR—To measure C15orf58 tran-
script levels in siRNA-transfected HEK293T cells, cDNA was
synthesized using RevertAidTM H Minus reverse transcriptase
(Fermentas, St. Leon-Rot, Germany) and random hexamers
according to the manufacturer’s protocol and adding 1 g of
RNA in a total volume of 20 l. We used 5 l of 20-fold diluted
reverse transcription reaction in subsequent 25-l quantitative
real time PCR reactions run in a MyiQTM thermal cycler with
SYBR Green as a fluorescent dye (Bio-Rad), HotStart Taq
polymerase (Eurogentec, Seraing, Belgium), and 0.3 M gene-
specific forward and reverse primers. PCRprogramswere 95 °C
for 5 min, 40 cycles at 95 °C for 10 s, and 60 °C for 1 min with
acquisition of fluorescence information followed by a melting
curve. Experiments shown represent averages for four biologi-
cal replicates. Primers used for amplification can be obtained
upon request.
Protein and Small Molecule Extraction from C. elegans and
Mouse Tissues—All steps of the described extraction proce-
dures were carried out at 4 °C. Brain, heart, liver, kidney, thy-
mus, and testes of C57BL6 mice were removed as quickly as
possible from sacrificed animals; frozen in liquid nitrogen; and
stored at 80 °C until further extraction. For protein extrac-
tion, the frozen tissues were placed in 3 volumes (v/w) of lysis
buffer (50 mM Tris-HCl, pH 7.5, 1 mM dithiothreitol, 2 mM
EDTA, 10% glycerol, Roche Complete protease inhibitor mix-
ture (1 tablet/50 ml), and 1 mM phenylmethylsulfonyl fluoride)
and homogenized in a Potter-Elvehjem apparatus. The homo-
genates were centrifuged at 21,000  g for 40 min, and the
supernatants were stored for enzymatic assays. For small mol-
ecule extraction, the frozen tissues were homogenized in a Pot-
ter-Elvehjemapparatus after addition of 2 volumes (v/w) of 10%
perchloric acid. After centrifugation of the homogenates at
21,000 g for 40 min, the supernatants were neutralized with
K2CO3.
Worms, harvested as described above, were resuspended in 2
volumes (v/w) of lysis buffer or 1 volume (v/w) of 10% perchlo-
ric acid. The worm suspensions were freeze-dropped in liquid
nitrogen and ground to a fine powder in a precooledmortar and
pestle. The homogenates were allowed to thaw on ice and cen-
trifuged at 21,000 g for 30 min. The supernatants of the per-
chloric acid extracts were neutralized with K2CO3. All protein
and smallmolecule extracts were stored at80 °C until assayed
for enzymatic activity or GDP-hexose content. Protein concen-
trationwas determined using the Lowry assay after protein pre-
cipitation with 10% trichloroacetic acid.
HPLC-based Nucleoside Diphosphate (NDP)-hexose Phos-
phorylase Assay—NDP-hexose phosphorylase activities of
recombinant enzymes, worm and mouse tissue extracts, and
HEK293T cell extracts were assayed bymeasuring NDP forma-
tion after incubation with NDP-hexose in a reaction mixture at
pH 7.5 containing 50 mM Tris-HCl or HEPES, 5 mM sodium
phosphate, 0 or 2 mM MgCl2, 0 or 1 mM EDTA, 10 mM NaCl,
and 1mMdithiothreitol. Recombinant enzymes,wormextracts,
and HEK293T cell extracts were generally assayed without
MgCl2 and always without EDTA in the reaction mixture.
Mouse tissue extractswere assayed in the absence ofMgCl2 and
in the presence of 1 mM EDTA. The salt and small molecule
content of worm, mouse tissue, and HEK293T cell extracts was
minimized by processing them on spin desalting columns
(Thermo Scientific, Rockford, IL) immediately before using
them for activity measurements. Desalting, omission of exter-
nally added Mg2, and/or addition of EDTA allowed minimi-
zation of NDP-hexose hydrolysis by contaminating nucleotide
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pyrophosphatase activities. Additionally, desalting of the pro-
tein extracts allowed the removal of compounds prone to inter-
fere with the enzymatic assay (inorganic phosphate, nucleo-
tides, and nucleotide derivatives). Reactions (at 26 °C for C.
elegans enzyme preparations and at 31 °C for mammalian
enzyme preparations) were initiated by enzyme addition and
stopped after 5–30 min by heating at 98 °C for 3 min. After
removal of precipitated protein by centrifugation, supernatants
were analyzed by anion exchange HPLC as described (1). NDP
andNDP-hexose concentrations were calculated by comparing
the integrated peak areas with those of standard NDP or NDP-
hexose solutions.
Spectrophotometric GDP-D-Glc Phosphorylase Assay—The
GDP-D-Glc phosphorylase activity of worm and human recom-
binant enzymes was also measured by a spectrophotometric
assay modified from Nihira et al. (20). Briefly, a reaction mix-
ture containing 60 mM Tris-HCl, pH 7.5, 2.4 mM NAD, 0–20
mM sodium phosphate, 12 mM MgCl2, 12 mM NaCl, 1.2 mM
dithiothreitol, 0–100 M GDP-D-Glc, 6 IU/ml phosphogluco-
mutase, and 6 IU/ml glucose-6-P dehydrogenase was prepared,
and 250 l of this mixture were added per well in a 96-well
plate. The latter was transferred to a plate reader (Molecular
Devices, Sunnyvale, CA) that monitored the absorbance at 340
nm. Recombinant enzymewas added after an5-min preincu-
bation at 26 or 31 °C, and linear production of NADH was
measured byA340 over a 10-min time period to determine the
rate of conversion of GDP-D-Glc to D-Glc-1-P. The light path
length for each well was measured via the plate reader SoftMax
Pro5 software before addition of the enzyme.
Microscopy—Nematodes were anesthetized using levamisole
(2 mg/ml) and mounted on 2% agarose pads. Cells were identi-
fied by comparing the position of GFP-positive areas viewed by
simultaneous fluorescence and differential interference con-
trast microscopy. Images were captured using a Zeiss Axio-
scope (Thornwood, NY) at 40 power magnification with an
attached Hamamatsu Orca-ER camera (Bridgewater, NJ) and
Volocity software (Improvision, Lexington, MA). All images
shown in this study were prepared by using Adobe Photoshop
Elements 8.0 software (San Jose, CA).
GDP-D-hexose Detection and Assay by Ion Pair Liquid
Chromatography-Electrospray Ionization Mass Spectrometry
(IP-LC-ESI-MS)—All experiments were carried out on an Agi-
lent 1200 HPLC system coupled to a 4000 QTRAP MS/MS
hybrid triple quadrupole/linear ion trap mass spectrometer
from Applied Biosystems (Foster City, CA). The HPLC system
was equipped with a PAL autosampler with thermostated tray
holders and stack (LEAP Technologies, Carrboro, NC). The
turbo electrospray ionization source of the 4000 QTRAP sys-
tem was operated in the negative ion mode. Q1 and Q3 were
operated in unit resolution. All system control, data acquisi-
tion, and mass spectral data evaluation were performed using
Analyst software version 1.4.2 from Applied Biosystems. The
GDP-D-hexose assay was based on the procedure of Coulier
et al. (21). A Luna 3-m C18(2) column (150  3.0 mm, Phe-
nomenex) was used with a Luna C18 security guard cartridge
(4 3.0mm, Phenomenex).Mobile phaseA consisted of 10mM
hexylamine as an ion pairing agent (Aldrich) in water adjusted
to pH 6.3 with acetic acid. Mobile phase B consisted of 90%
methanol, 10% 10 mM ammonium acetate, and 7.5 mM hexyl-
amine adjusted to pH 8.9 with ammoniumhydroxide. Amobile
phase gradient was used with a flow rate of 0.4 ml/min starting
at 100% A for 15 min followed by a linear gradient from 100 to
65%A over 18min, then holding at 65%A for 2min followed by
a linear gradient from65 to 100%A in 2min, and finally holding
for 13min at 100%A. The column temperature wasmaintained
at 40 °C, and the injection volume was 10 l. Mass detection
was carried out in the negative mode under the following con-
ditions: spray voltage at4.5 kV, heated capillary temperature
at 550 °C, curtain gas at 25, and collision gas at the medium
setting. The system was tuned using a stock solution of GDP-
D-Glc orGDP-D-Man (10M) inwater. The precursor-to-prod-
uct ion transitions in multiple reaction monitoring mode used
to detect GDP-D-Glc and GDP-D-Man were as follows: m/z
6043 362,m/z 6043 158,m/z 6043 210, andm/z 6043 343.
Both GDP-hexoses yielded the same precursor ion, m/z 604,
which produced the same four product ions (m/z 158, 210, 343,
and 362). However, the relative abundances at which these
product ions were generated differed between the two GDP-
hexoses, andwe chose product ionm/z 6043 362 to detect and
quantify GDP-D-Glc, whereas product ionm/z 6043 158 was
used to detect and quantify GDP-D-Man.
RESULTS
Characterization of C. elegans and Human Homologs of Ara-
bidopsis VTC2—TheArabidopsis VTC2 gene has recently been
shown to encode GDP-L-Gal phosphorylase, a highly regulated
enzyme that catalyzes the first committed step in the plant vita-
min C synthesis pathway (4). The presence of VTC2 homologs
in species that synthesize vitamin C via a metabolic pathway
different from that of plants (most non-primate mammals), in
species that donot synthesize vitaminC (e.g.primates including
humans), or in species where vitamin C synthesis has not been
generally established (invertebrates) (6, 22, 23) stimulated us to
characterize the human and C. elegans proteins to understand
their physiological function. These proteins share 25–30%
sequence identity over their enzyme length with VTC2 from
Arabidopsis thaliana (1). cDNAs of the humanVTC2 homolog
gene (C15orf58) and the C. elegans VTC2 homolog gene
(C10F3.4) were overexpressed in a bacterial expression system
as N-terminally His-tagged proteins and affinity-purified on
Ni2 columns.
Interestingly, the Gln residue of the conserved HXHXQ
motif in the plant VTC2 protein is replaced by a His residue in
the mammalian and invertebrate homolog proteins including
human C15orf58 and worm C10F3.4. The resulting HXHXH
motif constitutes the histidine triadmotif generally found in the
nucleotide hydrolase branch of the HIT protein superfamily,
whereas HXHXQ is the signaturemotif of the nucleotide trans-
ferase branch of this protein superfamily (12). To find out
whether the human and worm proteins act as nucleotide
hydrolases or transferases, we tested the activity of the recom-
binant enzymes on GDP-D-Glc, the preferred substrate for
plant VTC2 after GDP-L-Gal, in the absence or presence of
various potential nucleotide acceptors including inorganic
phosphate (Pi), inorganic pyrophosphate (PPi), L-Gal-1-P, and
D-Man-1-P (supplemental Fig. S1). The enzymatic activities
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were measured by HPLC-based methods that simultaneously
monitor the consumption of GDP-D-Glc and the formation of
the possible products (GMP,GDP,GTP,GDP-L-Gal, andGDP-
D-Man, respectively). Despite the replacement of the Gln resi-
due of theVTC2HITmotif by aHis residue in theHITmotifs of
the human and worm proteins, the latter did not hydrolyze
GDP-D-Glc. In fact, as for the VTC2 enzyme, the human and
worm VTC2 homologs only acted on GDP-D-Glc in the pres-
ence of Pi (supplemental Fig. S1), andGDP-D-Glc consumption
was accompanied by a concomitant formation of stoichiomet-
ric amounts of GDP (data not shown). These results showed
that the mammalian and invertebrate VTC2 homologs are, like
the plant enzyme, HIT nucleotide phosphorylases and not
hydrolases.
We then determined the kinetic parameters of these human
and worm phosphorylases for GDP-D-Glc, GDP-D-Man, and
GDP-L-Gal using the HPLC and/or the spectrophotometric
assays described under “Experimental Procedures” (Table 1).
For both enzymes, we found low micromolar Km values and
high catalytic efficiencies with GDP-D-Glc as a substrate. As
opposed to plant VTC2, which phosphorolyzesGDP-D-Glc and
GDP-L-Gal with similar catalytic efficiencies (1), the catalytic
efficiencies of the human and worm enzymes for GDP-L-Gal
were 35- and 750-fold lower, respectively, than for GDP-D-Glc.
GDP-D-Manwas, as for plant VTC2 (1), a poor substrate for the
human andwormphosphorylases. Also, as for plant VTC2 (24),
affinities in the low millimolar range were found with the
human and worm enzymes for the nucleotide acceptor Pi.
These results show that the human C15orf58 and worm
C10F3.4 proteins act as specific and highly efficient GDP-D-Glc
phosphorylases. The enzymatic activity of C10F3.4 was also
measured in the reverse direction by incubating the protein in
the presence of D-Glc-1-P and GDP, ADP, UDP, or CDP and
assaying NDP-D-Glc formation in the absence of added Pi (sup-
plemental Table S1). Significant NDP-D-Glc formation was
measured in these reactions in the presence of GDP.More than
10-fold lower activities were detected in the presence of UDP,
and no activity was found in the presence of CDP. Relatively
high ADP-D-Glc levels were measured after incubating D-Glc-
1-P in the presence ofADP, but this reactionwas not dependent
on the presence of the C10F3.4 enzyme (supplemental Table
S1). These results demonstrate the specificity of the enzyme for
the guanosine nucleotide at least in the presence of D-Glc-1-P.
The high substrate affinity of C15orf58 and C10F3.4 for
GDP-D-Glc made it relatively difficult to accurately determine
the kinetic parameters of their GDP-D-Glc phosphorylase
activity by the HPLC method; the product (GDP) concentra-
tions to be measured under initial velocity conditions at GDP-
D-Glc concentrations below and around the Km values of these
enzymes for GDP-D-Glc were close to the detection limit of the
assay.We therefore developed an enzymatic spectrophotomet-
ric assay to monitor D-Glc-1-P formation from GDP-D-Glc by
coupling this reaction to those catalyzed by phosphoglucomu-
tase and glucose-6-P dehydrogenase in the presence of NAD.
In this assay, the D-Glc-1-P formed is successively converted to
D-Glc-6-P and then to 6-phospho-D-glucono--lactone with
concomitant reduction of NAD to NADH, which is detected
by its UV absorbance at 340 nm. The Km values for GDP-D-Glc
obtained by this method for C15orf58 and C10F3.4 (3.4  1.0
and 10 4M, respectively) were similar to the values obtained
with the HPLC method (2.0  0.9 and 18  11 M, respec-
tively). Similar kcat values were also obtained for GDP-D-Glc
with human C15orf58 using the spectrophotometric assay
(16  0.4 s1) and the HPLC method (26  7 s1). However,
using the HPLC method, a non-Michaelis-Menten decrease in
activity was observed at higherGDP-D-Glc concentrationswith
the worm C10F3.4 enzyme (but not with the human C15orf58
enzyme). This inhibitory effect was not observed using the
spectrophotometric assay, suggesting that it might be due to
product inhibition and making the spectrophotometric assay
our preferred method for kinetic analyses of the GDP-D-Glc
phosphorylase activity of C10F3.4. Furthermore, the use of
these two different methods allowed us to confirm the identity
of the two products formed by the Pi-dependent conversion of
GDP-D-Glc by C15orf58 and C10F3.4 as D-Glc-1-P (spectro-
photometric assay) and GDP (HPLC method).
GDP-D-Glc Phosphorylase Activity in Mouse Tissue and
Worm Extracts—GDP-D-Glc phosphorylase activity was also
detected in mouse tissue and C. elegans extracts. The activity
levels measured in these extracts as the Pi-dependent GDP for-
mation from GDP-D-Glc (0.5–3 nmol min1 mg of protein1;
see Table 2 and Figs. 1 and 3) were of the same magnitude as
theGDP-L-Gal phosphorylase activitymeasured inArabidopsis
whole plant extracts (24). Under the assay conditions described
under “Experimental Procedures,” GDP formationmeasured in
the desalted protein extracts in the presence of GDP-D-Glc but
TABLE 1
Characterization of GDP-hexose phosphorylase activities of recombinant human C15orf58 and C. elegans C10F3.4 proteins
Km and Vmax values were obtained by fitting the experimental data to the Michaelis-Menten equation using the Km calculator of the BioMechanic program. Enzymatic
turnover numbers were derived from theVmax values by using amolecular mass of 45 and 55.7 kDa for His-tagged C15orf58 and C10F3.4, respectively, with the assumption
that the enzyme preparations were pure. Incubation times and enzyme concentrations were adjusted to obtain initial velocity data. Enzymatic activities were measured by
theHPLC assay described under “Experimental Procedures” except for theGDP-D-Glc phosphorylase activity of theC. elegans enzymewhere the spectrophotometric assay
described under “Experimental Procedures” was used. The worm and human recombinant enzymes were assayed at 26 and 31 °C, respectively. Km and Vmax values for the
GDP-hexoses were obtained in the presence of 5 mM inorganic phosphate, whereas those for inorganic phosphate were obtained in the presence of 50 M GDP-D-Glc.
Values are the means S.D. calculated from three to five individual experiments for each substrate except for inorganic phosphate for which the kinetic parameters of the
human enzyme were only determined twice.
Substrate
kcat Km kcat/Km
Human C. elegans Human C. elegans Human C. elegans
s1 mM s1 M1
GDP-D-Glc 26.0 7.4 265 15 0.0020 0.0009 0.010 0.004 1.5 0.8 107 3.0 1.2 107
GDP-D-Man 2.1 0.2 0.89 0.37 0.042 0.003 0.33 0.16 4.9 0.7 104 2.9 0.4 103
GDP-L-Gal 5.1 0.3 0.40 0.28 0.012 0.002 0.011 0.008 4.3 0.9 105 4.0 1.8 104
Inorganic phosphate 28.1 0.1 380 27 2.9 0.6 1.2 0.2 9.9 2.1 103 312 37 103
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in the absence of externally addedPiwas low (less than 0.2 nmol
min1 mg of protein1). Recapitulating the substrate specific-
ity for the recombinant C15orf58 and C10F3.4 proteins, a pref-
erence for GDP-D-Glc over GDP-L-Gal and GDP-D-Man was
also found in mouse brain extracts (Table 2) and in C. elegans
extracts (supplemental Table S2) when measuring Pi-depen-
dentGDP formation from theseGDP-hexoses. No (or very low)
phosphorylase activities were detected for human C15orf58
(Table 2) or worm C10F3.4 (supplemental Table S2) recombi-
nant proteins with other NDP-hexoses including GDP-L-Fuc,
UDP-D-Glc, UDP-D-Gal, and ADP-D-Glc. Similarly, little or no
phosphorylase activity toward GDP-L-Fuc, UDP-D-Glc, UDP-
D-Gal, and ADP-D-Glc was detected in mouse brain extracts
(Table 2) and C. elegans extracts (supplemental Table S2).
These results indicate that mammalian and worm tissues con-
tain a GDP-D-Glc phosphorylase activity with properties simi-
lar to those of the recombinantC15orf58 andC10F3.4 enzymes.
Confirmation of Identity of C10F3.4 and C15orf58 as C.
elegans and Human GDP-D-Glc Phosphorylases—To confirm
that the human and C. elegans GDP-D-Glc phosphorylases are
encoded by the C15orf58 and C10F3.4 genes, respectively, we
measured this enzymatic activity in extracts of cells where the
expression of these genes was eliminated or reduced.We used a
mutant C. elegans strain (tm2679) that has a 444-bp deletion
within the C10F3.4 gene. This deletion eliminates exons 6 to 7
and parts of exons 5 and 8 and introduces a premature stop
codon. The mutated allele encodes a predicted truncated 246-
amino acid protein that lacks the C-terminal moiety of the 458-
amino acid wild-type C10F3.4 protein (isoform a). Whereas
GDP-D-Glc phosphorylase activity could readily be measured
in wild-type C. elegans extracts, no such activity could be
detected in extracts prepared frommutant tm2679worms (Fig.
1A). Thesemutant worms, however, did not present any appar-
ent abnormal phenotype in the standard culture conditions
used throughout this study.
For the human enzyme, we knocked down theC15orf58 gene
in HEK293T cells by transfection with an siRNA pool specifi-
cally targeting this gene. As shown in Fig. 1B, a reduction of
about 50% in C15orf58 transcript level was obtained in cells
treatedwithC15orf58 siRNAs comparedwith cells treatedwith
non-targeting control siRNA. This decrease in mRNA expres-
sion level was accompanied by an2-fold decrease in GDP-D-
Glc phosphorylase activity in extracts derived from these cells
(Fig. 1B). These findings establish the molecular identity of the
C. elegans and human GDP-D-Glc phosphorylases as corre-
sponding to the expression products of the C10F3.4 and
C15orf58 genes, respectively.
FIGURE 1. GDP-D-Glc phosphorylase activity in C. elegans C10F3.4 deletion strain and in HEK293T cells treated with C15orf58 siRNA. Extracts were
prepared from wild-type (N2) or C10F3.4mutant (tm2679) C. elegans strains (A) and from siRNA-transfected HEK293T cells (B), and GDP-D-Glc phosphorylase
activity was measured by the HPLC assay described under “Experimental Procedures.” GDP-D-Glc was added to the reaction mixtures at a final concentration
of 50M. Theworm andHEK293T cell extracts were diluted in the reactionmixtures to final protein concentrations of 0.5–1.4 and 0.3–0.4mg/ml, respectively.
Control reactionswere run in the absenceof sodiumphosphate, andGDP-D-Glc phosphorylase activitieswere calculatedbasedon thePi-dependent formation
of GDP. A, worms were grown for 4–7 days at 20 °C in liquid culture and harvested for protein extraction. B, HEK293T cell cultures were stopped 48–72 h after
siRNA transfection. In addition to GDP-D-Glc phosphorylase activity assays (black bars), quantitative RT-PCR was performed on cDNA derived from these cells.
C15orf58 mRNA levels were normalized to those of ACTB (-actin; gray bars) or GAPDH (white bars), and -fold changes in C15orf58 expression in knockdown
versus control cells were calculated using the 2ddCt method. The results shown represent themeans S.D. of two to three (A) or four (B) biological replicates.
TABLE 2
Comparison of substrate specificity of human recombinant C15orf58
and of mouse brain GDP-D-Glc phosphorylase
Various sugar nucleotides (50 M) were incubated in the presence of C15orf58
recombinant enzyme (0.011 g/ml) for 25 min or of desalted mouse brain extracts
(0.3–0.5mg of protein/ml) for 20min at 31 °C. NDP-hexose consumption andNDP
production were measured by HPLC as described under “Experimental Proce-
dures.” Phosphorylase activities were calculated based on the Pi-dependent NDP
formation. With GDP-D-Glc as a substrate, the specific activity of the human
recombinant C15orf58 enzymewas 29.4 3.2molmin1mg of protein1 (100%);
the corresponding 100% specific activity of the mouse brain extract was 1.9  0.7
nmol min1 mg of protein1 (specific activities are means  S.D., n  2). The
phosphorylase activities found with the other sugar nucleotides are given as a per-
centage of the activity found with GDP-D-Glc. Values represent the means of two
individual experiments for each substrate.
Substrate
Relative specific activity
Recombinant
human enzyme
Mouse
brain extract
%
GDP-D-Glc 100 100
GDP-L-Gal 23 27
GDP-D-Man 2 5
GDP-L-Fuc 0 0
UDP-D-Glc 1 5
UDP-D-Gal 0 3
ADP-D-Glc 0 1
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Tissue Distribution of C. elegans and Mouse GDP-D-Glc
Phosphorylases—As a first step in elucidating the physiological
role of the GDP-D-Glc phosphorylase enzyme in worm and
mammalian tissues, we determined the tissue distribution of
this protein in live worms as well as of the corresponding activ-
ity in mouse extracts. A transgenic C. elegans strain (UZ119)
expressing a C10F3.4::GFP fusion protein under the endoge-
nous C10F3.4 promoter was used to determine in which cell
types and tissues this protein is expressed in nematodes.
Remarkably, significant expression of this protein seemed to be
mostly confined to neurons and parts of the reproductive sys-
tem. As shown in Fig. 2, cytosolic expression of the C10F3.4
protein was detected throughout the neuronal system. In addi-
tion, expression was observed in the spermatheca and in ante-
rior hypodermal cells. The high neuronal expression was found
in all the normal larval stages observed. C10F3.4 expressionwas
also detected in developing embryos.
To examine the tissue distribution of the GDP-D-Glc phos-
phorylase in mammals, we measured enzyme activity in
extracts of various mouse tissues. All of the analyzed tissues
contained GDP-D-Glc phosphorylase activity, but the highest
levels were reproducibly measured in brain and testis (4–8
times higher activities than in the remaining tissues; Fig. 3).We
also measured mRNA expression of the C15orf58 gene (desig-
natedD330012F22Rik inmouse) in variousmouse tissues using
real time quantitative PCR. The mRNA distribution pattern
revealed an up-regulation of the mouse C15orf58 homolog
mRNA in brain and testis relative to kidney, liver, and heart
FIGURE 2. C10F3.4 expression pattern in C. elegans. A transgenic C. elegans strain (UZ119) expressing a C10F3.4::GFP fusion protein was generated as
described under “Experimental Procedures.” The differential interference contrast images are presented in the left panels, GFP images are in themiddle panels,
andmerged images are in the right panels. C10F3.4::GFPexpression is seen inheadneurons (arrows) (A), in neuronal cells throughout theventral nerve cordand
in tail (lumbar) ganglia (arrow) (B), in the spermatheca (arrow) (C), and in anterior hypodermis cells (arrow in inset representing a magnified region) (D). The
bottom panels show a worm that lost the extrachromosomal array containing the C10F3.4::GFP transgene (E, negative control). Transgenic animals were
analyzed for GFP expression at 40 powermagnification.
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(supplemental Fig. S2), thus supporting the distribution pattern
obtained via GDP-D-Glc phosphorylase activitymeasurements.
Taken together, these results also demonstrated that, in addi-
tion to displaying similar substrate specificity and kinetic prop-
erties, the C. elegans and mammalian GDP-D-Glc phosphory-
lases share similar expression profiles with highest occurrence
in the nervous and male reproductive systems.
GDP-D-Glc Is Present at Low Levels in Nematode and
Mouse Tissues but Accumulates in Absence of GDP-D-Glc
Phosphorylase—Data on the presence and formation of GDP-
D-Glc in living organisms are scarce, but GDP-D-Glc has been
isolated from mammary gland (7). Furthermore, a GDP-D-Glc
pyrophosphorylase activity, formingGDP-D-Glc fromGTP and
D-Glc-1-P in the reverse reaction, has been measured in
extracts prepared from various mammalian (7, 8) and plant
sources (25). Although this activity could be clearly distin-
guished fromUDP-D-Glc pyrophosphorylase, it has most often
been found in associationwithGDP-D-Manpyrophosphorylase
activity (8–10) and may thus result from a lack of substrate
specificity of the enzyme that forms GDP-D-Man for glycocon-
jugate synthesis. We thus developed methods to directly mea-
sure GDP-D-Glc and GDP-D-Man in cell extracts.
We first set up a specific and sensitive assay of these GDP-
hexoses that was adapted from a previously published ion pair
liquid chromatography coupled to electrospray ionizationmass
spectrometry method (21) as described under “Experimental
Procedures.” This method allowed us to distinguish between
GDP-D-Man and GDP-D-Glc both by elution time and by the
relative abundance of product ions m/z 604 3 158 and m/z
604 3 362 (both generated from the common precursor ion
m/z 604) (Fig. 4A). GDP-D-Man reproducibly eluted earlier
from the LC column than GDP-D-Glc and consistently gener-
ated higher levels of product ion 6043 158 than of product ion
604 3 362 in the range of GDP-D-Man concentrations ana-
lyzed. GDP-D-Glc on the other hand generated higher levels of
the product ion 604 3 362. The 158/362 product ion peak
intensity ratio found for GDP-D-Man and GDP-D-Glc corre-
sponded to 3.4 and 0.13, respectively, over the range of GDP-
hexose concentrations analyzed in this study by the IP-LC-
ESI-MS method. For quantification, standard curves were
generated forGDP-D-Man andGDP-D-Glc by injecting 10–100
and 0.1–4 pmol of these compounds, respectively, in a volume
of 10 l and by determining the corresponding product ion
604 3 158 (GDP-D-Man) and 604 3 362 (GDP-D-Glc) peak
areas of the extracted ion current (supplemental Fig. S3). We
found that amounts of GDP-D-Glc corresponding to as low as
0.05 pmol could readily be detected by this method.
We then quantified GDP-D-Man and GDP-D-Glc in neutral-
ized perchloric acid extracts prepared from wild-type (N2) and
tm2679 mutant C. elegans worms grown in liquid culture and
from a series of mouse tissues as described under “Experimen-
tal Procedures” (Table 3). Similar amounts ofGDP-D-Manwere
found in tm2679 and N2 worms (7.7 versus 8.9 nmol/g of
worms), whereas more than 5-fold higher amounts of GDP-D-
Glc were detected in the C10F3.4 deletion strain versus wild-
type worms (0.11 versus 0.02 nmol/g of worms). It should be
noted that the GDP-D-Glc levels found in wild-type worms
were actually close to the detection limit of our assay. This
observation indicated that the best substrate found in vitro for
the C10F3.4 phosphorylase is a physiological substrate for this
enzyme in worms. Concerning wild-type mouse tissues, GDP-
D-Man concentrations varying from about 7 to 25 nmol/g of
tissue (wet weight) were measured; liver was the organ with the
highest levels of this GDP-hexose (Table 3). These values were
similar to GDP-D-Man concentrations found previously in rat
tissues (26). GDP-D-Glc levels were very low in all of the mouse
tissues analyzed. The highest GDP-D-Glc levels were measured
in liver (0.15 nmol/g of tissue) where GDP-D-Glc concentra-
tions were found to be more than 100-fold lower than GDP-D-
Man concentrations. The GDP-D-Glc levels detected in brain,
kidney, testis, and heart were 15–30-fold lower than in liver.
Except for liver, all of the GDP-D-Glc levels found in mouse
tissues were near or below the detection limit of our assay.
Taken together, these results suggest that GDP-D-Glc levels are
normally maintained at very low levels in cells. The only situa-
tion in which we found more significant GDP-D-Glc levels was
in extracts of a C. elegans mutant of the C10F3.4 GDP-D-Glc
phosphorylase activity. We conclude that a physiological func-
tion of GDP-D-Glc phosphorylase in nematode cells is to
degrade GDP-D-Glc to D-Glc-1-P and hypothesize that such an
activity is needed to prevent misincorporation of glucose for
mannose into glycoconjugates (Fig. 5). The situation in mam-
malian cells may be similar.
DISCUSSION
In an effort to understand the function of apparent orthologs
of the plant VTC2 enzyme in non-plant organisms, we found
that C. elegans and mammalian tissues contain a specific GDP-
D-Glc phosphorylase enzyme encoded by the C10F3.4 gene in
worms and the C15orf58 gene in humans. As opposed to the
plant VTC2 enzyme, the C10F3.4 and C15orf58 proteins dis-
play a marked preference for GDP-D-Glc over GDP-L-Gal as a
substrate. However, like the VTC2 enzyme, the C10F3.4 and
C15orf58 enzymes are also completely dependent on the pres-
FIGURE 3. Tissue distribution of GDP-D-Glc phosphorylase activity in
mouse.Mouse tissue extracts were prepared, and GDP-D-Glc phosphorylase
activities were measured by HPLC as described under “Experimental Proce-
dures.” GDP-D-Glc andmouse tissue extracts were added to the reactionmix-
tures at final concentrations of 50 M and 0.3–1.5 mg of protein/ml, respec-
tively. Control reactions were run in the absence of sodium phosphate, and
GDP-D-Glc phosphorylase activities were calculated based on the Pi-depen-
dent formationofGDP. The results shown represent themeansS.D. of three
to five biological replicates.
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ence of inorganic phosphate to act onGDP-D-Glc, thereby con-
verting it into D-Glc-1-P and GDP. The identity of the reaction
products was confirmed by HPLC (for GDP) and by an enzy-
matic spectrophotometric assay (for D-Glc-1-P).
The Pi dependence of the C10F3.4 and C15orf58 enzymes
was somewhat unexpected given that the Gln residue of the
VTC2 “HIT motif” (HXHXQ) was replaced by a His residue in
the HIT motifs of both the worm and human VTC2 homolog
sequences (HXHXH). So far, the HXHXH motif has been pro-
posed to be characteristic of HIT nucleotide hydrolases,
whereas theHXHXQmotif has been considered as predictive of
a nucleotide transferase or phosphorylase activity (11, 12). The
present study and two other recent reports indicate that this
“rule” has exceptions. In addition to C10F3.4 and C15orf58, a
mycobacterial protein (Rv2613c) containing a HXHXH motif
has also recently been reported to act as a phosphorylase (on
diadenosine tetraphosphate) and not as a hydrolase (27). Fur-
thermore, A. thaliana Hint4 and C. elegans DcpS, two HIT
proteins containing the HXHXH motif, have been shown to
display a phosphorolytic activity toward adenosine 5-phos-
phosulfate in addition to their hydrolytic activity on this sub-
strate (28). The phosphorylase activity of the latter two
enzymes, however, was minor compared with their hydrolase
activity at neutral pH. Taken together, these results suggest that
critical residues other than the C-terminal residue of the HIT
motif (His orGln)must be involved in determiningwhether the
nucleotidylated enzyme intermediate that is formed during
HIT enzyme-catalyzed reactions is resolved via hydrolysis or
phosphorolysis.
Concerning the nucleotide moiety of the nucleotide sugar
substrate, recombinant C10F3.4 and C15orf58 appear to be
specific for GDP as none of the ADP- or UDP-hexoses tested
were phosphorolyzed by either of these proteins and as GDP
could not be replaced in the reverse reaction by ADP, UDP,
FIGURE4.AccumulationofGDP-D-Glc inC10F3.4mutantC. elegans strain (tm2679).GDP-D-ManandGDP-D-Glc standards (A) andwild-typeN2andmutant
tm2679 smallmolecule extracts (B) were analyzedby the IP-LC-ESI-MSmethoddescribedunder “Experimental Procedures.”A, extracted ion chromatogramsof
product ionsm/z 6043 158 (middle panel,white area) andm/z 6043 362 (bottom panel, black area) obtained after injection of a solution containing 0.2 pmol
of GDP-D-Man and 0.2 pmol of GDP-D-Glc. GDP-D-Man and GDP-D-Glc produced the same precursor ion,m/z 604, and the same product ions,m/z 6043 158
andm/z 6043 362. These GDP-hexoses, however, displayed different retention times with GDP-D-Man eluting first and different relative peak intensities for
the product ions. The top panel shows an overlay of the extracted ion chromatograms of product ionsm/z 6043 158 (white area) andm/z 6043 362 (black
area) presented separately in themiddleandbottompanels.B, extracted ionchromatogramsofproduct ionsm/z6043158 (middle panels,white areas) andm/z
6043362 (bottompanels,black areas) after injectionof equal volumesofC. elegansN2and tm2679perchloric acid extracts. The toppanels showoverlays of the
correspondingmiddle and bottom panels. The arrows indicate the peak identified as GDP-D-Glc and accumulating in C10F3.4mutant worms. Representative
chromatograms obtained with one set of wild-type and mutant extracts are shown. Four other sets of wild-type and tm2679mutant extracts were analyzed
with similar results. The GDP-D-Man and GDP-D-Glc levels found in these worm extracts were quantified, and the values obtained are given in Table 3. cps,
counts/s.
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or CDP for transfer to D-Glc-1-P. As to the sugar moiety of
the GDP-sugar substrate, the C10F3.4 and C15orf58
enzymes displayed a marked preference for D-Glc over L-Gal,
D-Man, and L-Fuc. A similar substrate specificity was found
for the GDP-hexose phosphorylase activity detected in C.
elegans and mouse tissue extracts. This finding as well as the
absence of GDP-D-Glc phosphorylase activity in mutant
worms lacking a functional C10F3.4 gene and decreased
GDP-D-Glc phosphorylase activity in C15orf58 siRNA
knockdown human cells led us to conclude that C10F3.4 and
C15orf58 encode for the C. elegans and human GDP-D-Glc
phosphorylase enzymes, respectively.
A link of the mammalian VTC2 homolog to vitamin C syn-
thesis seemed very unlikely because mammals (except for a few
non-ascorbate-synthesizing species including humans) synthe-
size ascorbate via a pathway that is different from the plant
pathway and that does not involve GDP-L-Gal as an intermedi-
ate (6). However, the presence of a VTC2-homologous gene in
C. elegans raised questions concerning a possible existence of a
plant-like ascorbate biosynthesis pathway in this species. The
finding that the C10F3.4 enzyme was more than 700-fold less
efficient in phosphorolyzingGDP-L-Gal thanGDP-D-Glc, how-
ever, was a first indication that this enzyme is not likely to par-
ticipate in a plant-like vitamin C synthesis pathway in C.
elegans. Interestingly, we could actually detect significant
amounts of ascorbate in C. elegans worms, but similar levels
were found in wild-type and C10F3.4 mutant worms,5 again
arguing against C10F3.4 involvement in ascorbate formation in
worms. Combining these observations with the absence of any
obvious orthologs of critical enzymes of the plant vitamin C
biosynthesis pathway (e.g. GDP-D-mannose 3,5-epimerase and
L-galactonolactone dehydrogenase) in C. elegans (1), we con-
clude that if ascorbate is formed in this species it is not via a
plant-like L-galactose pathway involving the C10F3.4 enzyme.
Our characterization of the substrate specificity and kinetic
properties of the C10F3.4 and C15orf58 proteins and the
observed accumulation of GDP-D-Glc in C10F3.4-deficient
worms indicate that GDP-D-Glc is a physiological substrate of
these enzymes. Why would invertebrates and vertebrates have
conserved an enzyme that breaks downGDP-D-Glc into D-Glc-
1-P and GDP? The literature on GDP-D-Glc is scarce, but the
presence of this GDP-hexose was reported in the early 1960s in
lactating bovine mammary gland (7), and an enzymatic activity
forming GDP-D-Glc from GTP and D-Glc-1-P (GDP-D-Glc
pyrophosphorylase) has also been found in various plant (25)
and animal tissues (8, 9). At least in mammals, however, this
activity has so far always been found in association with GDP-
D-Man pyrophosphorylase. Nothing is known about possible
functions of GDP-D-Glc in mammals or invertebrates, but
GDP-D-Glc acts as a glucosyl donor for the synthesis of cell wall
polysaccharides in various plant species (29–32) and for treha-
lose synthesis in certain bacterial species (33).
Mammalian GDP-D-Man pyrophosphorylase has been
purified from rat mammary gland and calf liver (8), from pig
thyroid (34), and from pig liver (9). Although the thyroid
enzyme was specific for GDP-D-Man, both the mammary
gland and liver enzymes have been shown to use GDP-D-Man
as well as GDP-D-Glc as substrates. Remarkably, the native
pig liver enzyme was actually about 2 times more active in
forming GDP-D-Glc than in the synthesis of GDP-D-Man
(10). This enzyme is composed of two different subunits (-
and -subunits) encoded by two different genes. Only the
gene encoding the -subunit has so far been cloned and
expressed (10). The expression product of this gene was
shown to be a functional GDP-D-Man pyrophosphorylase
that, unlike the native enzyme, is about 6 times more active
in forming GDP-D-Man than GDP-D-Glc. Based on this, it
was suggested that the -subunit could be the GDP-D-Glc
pyrophosphorylase or a regulatory subunit that affects the
substrate specificity of the -subunit. It is of interest to note
here that genes encoding homologs of the - and -subunits
of GDP-D-Man pyrophosphorylase are also found in the C.
elegans genome. On the contrary, no gene encoding an
-subunit is found in the genome of Saccharomyces cerevi-
siae, and the GDP-D-Man pyrophosphorylase of this species,
which presents high similarity with mammalian GDP-D-
Man pyrophosphorylase , has been reported to be quite
specific for GDP-D-Man (10). The S. cerevisiae genome does
not encode a VTC2 homolog either. Taken together, these
results suggest a link between the formation of GDP-D-Glc
by a second activity of the enzyme that normally makes
GDP-D-Man and the presence of a GDP-D-Glc phosphoryl-
ase that specifically degrades the glucose-containing
nucleotide sugar. In favor of this, we found a similar tissue
distribution pattern of GDP-D-Glc phosphorylase and GDP-
D-Man pyrophosphorylase  (Gmppa) at the mRNA level in
mice (supplemental Fig. S2).
GDP-D-Man is the major mannosyl donor for the synthe-
sis ofN-linked glycoproteins and glycosylphosphatidylinosi-
tol membrane anchors (35). It is also the precursor of GDP-5 B. D. Young and L. N. Adler, unpublished results.
TABLE 3
GDP-D-Man and GDP-D-Glc levels in C. elegans and various mouse
tissues
GDP-D-Man and GDP-D-Glc levels were determined in neutralized perchloric acid
extracts of wild-type (N2) andC10F3.4mutant (tm2679) worms aswell as of various
mouse tissues by using the IP-LC-ESI-MS method described under “Experimental
Procedures.” GDP-hexose concentrations were determined based on peak areas of
selected product ions (6043 362 for GDP-D-Glc and 6043 158 for GDP-D-Man)
and calibration curves establishedwith standardGDP-D-Man andGDP-D-Glc solu-
tions. Metabolite concentrations were normalized against wet worm or mouse tis-
sue weight. Values are means  S.D. of five (C. elegans) or two (mouse tissue)
biological replicates. Statistical analysis using a two-tailed unpaired Student’s t test
shows a statistically significant difference in GDP-D-Glc concentration and GDP-
D-Glc/GDP-D-Man ratio between the N2 and tm2679 C. elegans strains as demon-
strated by the indicated p values.
Strain
C. elegans
GDP-D-Man GDP-D-Glc GDP-Glc/GDP-Man
nmol/g worms nmol/g worms 103
N2 8.9 5.4 0.020 0.009 2.3 0.7
tm2679 7.7 4.6 0.11 0.07
(p 0.029)
13.8 2.2
(p 0.000004)
Tissue
Mouse
GDP-D-Man GDP-D-Glc GDP-Glc/GDP-Man
nmol/g tissue nmol/g tissue 103
Liver 25 2 0.15 0.01 6.1 0.1
Brain 13 0.2 0.0077 0.0012 0.6 0.02
Kidney 6.8 0.4 0.0096 0.0002 1.4 0.06
Testis 11 0.1 0.0052 0.0016 0.48 0.14
Heart 7.8 0.5 0.0055 0.0018 0.70 0.27
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L-Fuc, another important glycosyl donor for glycoprotein
biosynthesis (35). In various bacterial, lower eukaryotic, and
plant species, GDP-D-Man donates mannosyl residues for
cell wall polysaccharides (32, 36, 37). Given the close struc-
tural similarity of GDP-D-Man and GDP-D-Glc (they only
differ by the configuration of their hydroxyl group on C2 of
the sugar moiety), it can be hypothesized that some of the
enzymes using GDP-D-Man are not entirely specific for their
substrate and can use GDP-D-Glc instead (or be competi-
tively inhibited by the latter). In favor of this, glycosyltrans-
ferases that use nucleotide sugars as the glycosyl donors
seem to be often particularly specific for the nucleotide por-
tion of their substrate while having some tolerance for dif-
ferent sugars (38). This lack of specificity could be indirectly
corrected by keeping the concentrations of GDP-D-Glc low
enough for not entering in competition with GDP-D-Man.
As described in this study, GDP-D-Glc concentrations are
indeed very low in wild-type worm andmouse tissues, which,
in addition to the apparent absence of any physiological
function of GDP-D-Glc in these species, supports the idea
that GDP-D-Glc phosphorylase functions as a metabolite
repair enzyme.
The concept of metabolite repair is based on the observa-
tion that certain enzymes are not as specific as generally
stated and sometimes form “unwanted” side products by
acting on cellular compounds different from their main sub-
strate (39). A metabolite repair enzyme functions to specifi-
cally remove such unwanted side products. L-2-Hydroxy-
glutarate dehydrogenase is the first example of a metabolite
repair enzyme that has been molecularly identified; it acts to
remove the toxic product formed by L-malate dehydrogenase
when this enzyme acts on -ketoglutarate instead of its main
substrate oxaloacetate (40). The physiological importance of
this enzyme is demonstrated by the severe consequences of
its deficiency, which leads to a neurometabolic disease
known as L-2-hydroxyglutaric aciduria (39). GDP-D-Glc
phosphorylase could serve to compensate for the lack of
specificity of GDP-D-Man pyrophosphorylase, which, as
described above, is quite active in forming GDP-D-Glc in
vitro (10). It seems surprising that such an activity would
FIGURE 5.Possible role of GDP-D-Glc phosphorylase in preventingmisincorporation of glucose in place ofmannose residues into glycoconjugates. In
the presence of GTP and D-Man-1-P, GDP-D-Man pyrophosphorylase forms GDP-D-Man, a major mannosyl donor for glycoconjugation. The native pyrophos-
phorylase is composedof- and-subunits (GMPPAandGMPPB) andhas been shown to also catalyze the formation ofGDP-D-Glcwhen D-Man-1-P is replaced
by D-Glc-1-P. However, we show in this study thatmammalian tissues contain only very low levels of GDP-D-Glc. In addition, this nucleotide sugar accumulates
inmutantworms lackingGDP-D-Glc phosphorylase, the enzymedescribed in the presentwork.We therefore propose that GDP-D-Glc phosphorylase functions
to compensate for the lack of specificity of GDP-D-Man pyrophosphorylase by degrading the apparently useless GDP-D-Glc. This may be important to prevent
misincorporation of glucose residues formannose residues into oligosaccharide chains such as those linked to dolichol (this figure) and eventually transferred
to proteins. GDP-D-Glc phosphorylase might thus be necessary to preserve functional protein N-glycosylation or other glycoconjugation processes. ER,
endoplasmic reticulum.
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have been conserved if there is no need for GDP-D-Glc in the
cell. It is therefore tempting to speculate that this enzyme is
regulated intracellularly in a way that this GDP-D-Glc-form-
ing activity of GDP-D-Man pyrophosphorylase is inhibited to
a certain extent, potentially via its composition in - and
-subunits. The remaining D-Glc-1-P guanylyltransferase
activity could then be indirectly corrected by GDP-D-Glc
phosphorylase through removal of the GDP-D-Glc formed
(see Fig. 5). It can be noted here that the activity levels
reported for D-Glc-1-P guanylyltransferase in mammalian
tissues (8) are in the same range as the activity levels found in
this study for GDP-D-Glc phosphorylase in mammalian tis-
sues; in liver for example, a value of about 0.6 nmolmin1 mg
of protein1 has been found for both of these activities.
Combined with the high affinity for GDP-D-Glc that we
determined for GDP-D-Glc phosphorylase, this enzyme has
the required properties to efficiently remove the apparently
useless GDP-hexose.
In this metabolite repair hypothesis, a deficiency in GDP-
D-Glc phosphorylase activity could lead to GDP-D-Glc accu-
mulation as we observed in worms deficient in this en-
zyme and subsequent erroneous incorporation of glucosyl
units instead of mannosyl units into oligosaccharide chains
(Fig. 5). If GDP-D-Glc is formed in vivo by GDP-D-Man pyro-
phosphorylase, the cytosolic mannosyltransferases (includ-
ing ALG1, ALG2, and ALG11) involved in the protein N-
glycosylation pathway should be most prone to encounter
accumulating GDP-D-Glc molecules. These cytosolic man-
nosyltransferases successively add five mannosyl residues
from GDP-D-Man to dolichol-PP-(GlcNAc)2. The dolichol-
PP-(GlcNAc)2Man5 intermediate is then flipped to the endo-
plasmic reticulum lumen where this lipid-linked oligosac-
charide (LLO) is further extended and finally transferred to
Asn residues on newly synthesized polypeptide chains (35).
It is difficult to predict the consequences of the replacement
of mannosyl residues by glucosyl residues in LLO, but, as for
the numerous inherited deficiencies in LLO assembly (con-
genital disorders of glycosylation type I (CDG-I)) already
identified, this could lead to the production of structurally
incomplete LLOs, resulting in hypoglycosylation of multiple
glycoproteins (35, 41). It will therefore be of great interest to
screen for mutations in the C15orf58 gene in CDG-I patients
for which the basic defect has yet to be elucidated (CDG-Ix
patients; Ref. 42). The high expression of GDP-D-Glc phos-
phorylase in the nervous system suggests a greater vulnera-
bility of this organ to GDP-D-Glc accumulation, which is
compatible with the pronounced neurological symptoms
that are very commonly observed in CDG-I patients. As LLO
is synthesized in C. elegans by the common eukaryotic path-
way (43), the C10F3.4 mutant strain might provide a good
model for the identification of potential glycosylation
defects caused by GDP-D-Glc phosphorylase deficiency. It
should be noted, however, that worms appear to be more
resistant to such defects than humans as no overt pheno-
types have been observed upon RNA interference against
certain genes of the LLO synthesis pathway in worms grown
in standard culture conditions (43).
In conclusion, we identified a novel enzyme, GDP-D-Glc
phosphorylase, potentially involved in metabolite repair in
nematodes andmammals (Fig. 5). Ongoing work is designed to
better understand the molecular basis of the GDP-D-Glc-form-
ing activity of GDP-D-Man pyrophosphorylase and to test
whether GDP-D-Glc phosphorylase is needed for functional
glycoprotein biosynthesis.
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